CD8A and neoplasm: found that abnormal overexpression of MUC1 significantly exacerbates tumor progression, while inhibiting MUC1 expression can reduce inflammation and tumor progression, marked by increased CD8+ T lymphocytes and reduced macrophages in tumors (109).